Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals

Boehringer Ingelheim2,318 enrolled

Overview

The aim of the observational study was to supplement the data on efficacy, safety and tolerability of telmisartan under daily conditions in hospitals

Study Type

OBSERVATIONAL

Enrollment

2,318

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with diagnosis of essential hypertension * Minimum age of 18 years Exclusion Criteria: * NA

Change in clinic blood pressure

Time frame: up to 14 days

Number of patients with adverse drug reactions

Time frame: up to 14 days

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.